Talis Biomedical Corporation (TLIS)

NASDAQ: TLIS · IEX Real-Time Price · USD

8.74

+0.07 (0.81%)

At close: Jul 19, 2024, 4:00 PM

8.57

-0.17 (-1.95%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Talis Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0.99	2.13	4.81	8.19	10.94	3.98	Upgrade
Revenue Growth (YoY)	-65.21%	-55.65%	-41.27%	-25.10%	175.03%	66.40%	Upgrade
Cost of Revenue	0.03	0.04	8.39	0	0	0	Upgrade
Gross Profit	0.96	2.09	-3.58	8.19	10.94	3.98	Upgrade
Selling, General & Admin	33.47	28.21	40.73	42.42	13.1	6.86	Upgrade
Research & Development	29.43	40.69	70.83	157.59	89.02	23.81	Upgrade
Operating Expenses	62.9	68.91	111.56	200.01	102.12	30.68	Upgrade
Operating Income	-61.94	-66.82	-115.14	-191.82	-91.18	-26.7	Upgrade
Other Expense / Income	-4.72	-4.81	-2.13	0.22	-0.05	0.78	Upgrade
Pretax Income	-57.21	-62.01	-113.01	-192.04	-91.13	-27.47	Upgrade
Net Income	-57.21	-62.01	-113.01	-192.04	-91.13	-27.47	Upgrade
Preferred Dividends	0	0	0	0	0	-53.86	Upgrade
Net Income Common	-57.21	-62.01	-113.01	-192.04	-91.13	26.38	Upgrade
Shares Outstanding (Basic)	2	2	2	2	0	0	Upgrade
Shares Outstanding (Diluted)	2	2	2	2	0	0	Upgrade
Shares Change	0.51%	0.95%	19.21%	968.49%	-1.41%	309.46%	Upgrade
EPS (Basic)	-31.43	-34.12	-62.77	-127.20	-644.70	515.10	Upgrade
EPS (Diluted)	-31.43	-34.12	-62.77	-127.20	-644.70	-191.55	Upgrade
Free Cash Flow	-43.63	-53.73	-101.75	-174.25	-95.23	-24.9	Upgrade
Free Cash Flow Per Share	-23.95	-29.56	-56.51	-115.37	-673.66	-486.17	Upgrade
Gross Margin	97.27%	98.08%	-74.38%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-6262.39%	-3130.97%	-2392.75%	-2341.22%	-833.64%	-671.34%	Upgrade
Profit Margin	-5784.73%	-2905.67%	-2348.55%	-2343.90%	-833.15%	663.36%	Upgrade
Free Cash Flow Margin	-4411.93%	-2517.62%	-2114.53%	-2126.82%	-870.59%	-626.20%	Upgrade
EBITDA	-52.43	-56.93	-101.41	-189.42	-89.76	-26.75	Upgrade
EBITDA Margin	-5301.42%	-2667.90%	-2107.46%	-2311.91%	-820.59%	-672.57%	Upgrade
Depreciation & Amortization	4.78	5.07	11.6	2.62	1.37	0.73	Upgrade
EBIT	-57.21	-62.01	-113.01	-192.04	-91.13	-27.47	Upgrade
EBIT Margin	-5784.73%	-2905.67%	-2348.55%	-2343.90%	-833.15%	-690.82%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).